Lexston Life Sciences has an EPS of $-0.04. In 2022, the company made an earnings per share (EPS) of $-0.21. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
Year | EPS | Change |
---|---|---|
2023 | -$0.04 | -80.95% |
2022 | -$0.21 | 139.54% |
2021 | -$0.087669 | - |